Tasneem Z. Naqvi, MD1
Articles
Iatrogenic dilated cardiomyopathy and spectrum of current treatment modalities
Tasneem Z. Naqvi, MD1;Jing Zhang MD, PhD2;Leslie Saxon, MD1: From the 1Division of Cardiology, University of Southern California, Keck School of Medicine;the Department of Anesthesia Cardiovasc
September 4th 2008Our increasing ability to intervene in high-risk patients—with lower risks and greater chances for successful outcomes—is felt across the broad spectrum of cardiovascular disease. This is particularly evident in patients with dilated cardiomyopathy (DCM).
Read More
Latest Updated Articles
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Published: February 21st 2025 | Updated: February 23rd 2025
Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MD
Published: February 21st 2025 | Updated: February 23rd 2025
Tapinarof Demonstrates Consistent Efficacy Across Body Regions in People With Atopic Dermatitis
Published: February 27th 2024 | Updated: February 23rd 2025
Once-Daily Berotralstat Treatment for HAE Consistently Decreases Attack Occurrences
Published: February 19th 2025 | Updated: February 23rd 2025
Best Practices in Managing Indolent Systemic Mastocytosis (ISM)
